BAYER AG-REG (BAYN.DE) Fundamental Analysis & Valuation

FRA:BAYN • DE000BAY0017

39.625 EUR
+2.03 (+5.41%)
Last: Mar 10, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This BAYN.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Overall BAYN gets a fundamental rating of 2 out of 10. We evaluated BAYN against 54 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of BAYN have multiple concerns. BAYN has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

1

1. BAYN.DE Profitability Analysis

1.1 Basic Checks

  • BAYN had positive earnings in the past year.
  • BAYN had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: BAYN reported negative net income in multiple years.
  • Of the past 5 years BAYN 4 years had a positive operating cash flow.
BAYN.DE Yearly Net Income VS EBIT VS OCF VS FCFBAYN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

  • BAYN's Return On Assets of -0.19% is on the low side compared to the rest of the industry. BAYN is outperformed by 62.96% of its industry peers.
  • Looking at the Return On Equity, with a value of -0.67%, BAYN is doing worse than 64.81% of the companies in the same industry.
  • With a Return On Invested Capital value of 1.80%, BAYN is not doing good in the industry: 62.96% of the companies in the same industry are doing better.
  • BAYN had an Average Return On Invested Capital over the past 3 years of 5.51%. This is significantly below the industry average of 14.78%.
Industry RankSector Rank
ROA -0.19%
ROE -0.67%
ROIC 1.8%
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.51%
ROIC(5y)N/A
BAYN.DE Yearly ROA, ROE, ROICBAYN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

  • Looking at the Operating Margin, with a value of 4.20%, BAYN is doing worse than 64.81% of the companies in the same industry.
  • BAYN's Operating Margin has declined in the last couple of years.
  • BAYN has a worse Gross Margin (56.35%) than 70.37% of its industry peers.
  • In the last couple of years the Gross Margin of BAYN has declined.
Industry RankSector Rank
OM 4.2%
PM (TTM) N/A
GM 56.35%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
BAYN.DE Yearly Profit, Operating, Gross MarginsBAYN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. BAYN.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BAYN is destroying value.
  • BAYN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BAYN.DE Yearly Shares OutstandingBAYN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
BAYN.DE Yearly Total Debt VS Total AssetsBAYN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

  • Based on the Altman-Z score of 0.96, we must say that BAYN is in the distress zone and has some risk of bankruptcy.
  • BAYN has a worse Altman-Z score (0.96) than 70.37% of its industry peers.
  • The Debt to FCF ratio of BAYN is 10.07, which is on the high side as it means it would take BAYN, 10.07 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 10.07, BAYN is doing worse than 64.81% of the companies in the same industry.
  • A Debt/Equity ratio of 1.11 is on the high side and indicates that BAYN has dependencies on debt financing.
  • BAYN has a worse Debt to Equity ratio (1.11) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 10.07
Altman-Z 0.96
ROIC/WACC0.26
WACC6.93%
BAYN.DE Yearly LT Debt VS Equity VS FCFBAYN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

  • BAYN has a Current Ratio of 1.14. This is a normal value and indicates that BAYN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.14, BAYN is doing worse than 64.81% of the companies in the same industry.
  • BAYN has a Quick Ratio of 1.14. This is a bad value and indicates that BAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.71, BAYN is not doing good in the industry: 81.48% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.71
BAYN.DE Yearly Current Assets VS Current LiabilitesBAYN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. BAYN.DE Growth Analysis

3.1 Past

  • BAYN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.99%.
  • Measured over the past years, BAYN shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.00% on average per year.
EPS 1Y (TTM)-11.99%
EPS 3Y-17.58%
EPS 5Y-7%
EPS Q2Q%-85.26%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.41%

3.2 Future

  • BAYN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.22% yearly.
  • BAYN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.62% yearly.
EPS Next Y5.3%
EPS Next 2Y6.88%
EPS Next 3Y9.93%
EPS Next 5Y6.22%
Revenue Next Year0.65%
Revenue Next 2Y1.52%
Revenue Next 3Y2.48%
Revenue Next 5Y2.62%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BAYN.DE Yearly Revenue VS EstimatesBAYN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
BAYN.DE Yearly EPS VS EstimatesBAYN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

7

4. BAYN.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 8.92, the valuation of BAYN can be described as reasonable.
  • Based on the Price/Earnings ratio, BAYN is valued cheaply inside the industry as 92.59% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of BAYN to the average of the S&P500 Index (26.25), we can say BAYN is valued rather cheaply.
  • BAYN is valuated reasonably with a Price/Forward Earnings ratio of 8.47.
  • Based on the Price/Forward Earnings ratio, BAYN is valued cheaply inside the industry as 96.30% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of BAYN to the average of the S&P500 Index (24.39), we can say BAYN is valued rather cheaply.
Industry RankSector Rank
PE 8.92
Fwd PE 8.47
BAYN.DE Price Earnings VS Forward Price EarningsBAYN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 66.67% of the companies in the same industry are more expensive than BAYN, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BAYN indicates a rather cheap valuation: BAYN is cheaper than 92.59% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.89
EV/EBITDA 11.06
BAYN.DE Per share dataBAYN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.68
PEG (5Y)N/A
EPS Next 2Y6.88%
EPS Next 3Y9.93%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BAYN.DE Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.29%, BAYN is not a good candidate for dividend investing.
  • BAYN's Dividend Yield is slightly below the industry average, which is at 1.91.
  • Compared to an average S&P500 Dividend Yield of 1.82, BAYN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.29%

5.2 History

  • The dividend of BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years3
BAYN.DE Yearly Dividends per shareBAYN.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • The earnings of BAYN are negative and hence is the payout ratio. BAYN will probably not be able to sustain this dividend level.
DP-65.15%
EPS Next 2Y6.88%
EPS Next 3Y9.93%
BAYN.DE Yearly Income VS Free CF VS DividendBAYN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

More info and screens

Find the best dividend stocksShow peers with best dividend

BAYN.DE Fundamentals: All Metrics, Ratios and Statistics

BAYER AG-REG

FRA:BAYN (3/10/2026, 7:00:00 PM)

39.625

+2.03 (+5.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-04
Earnings (Next)05-12
Inst Owners51.38%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap38.93B
Revenue(TTM)N/A
Net Income(TTM)-198.00M
Analysts73.1
Price Target42.36 (6.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.29%
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-65.15%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.52%
Min EPS beat(2)45.89%
Max EPS beat(2)71.16%
EPS beat(4)4
Avg EPS beat(4)30.58%
Min EPS beat(4)1.86%
Max EPS beat(4)71.16%
EPS beat(8)7
Avg EPS beat(8)18.15%
EPS beat(12)9
Avg EPS beat(12)7.9%
EPS beat(16)12
Avg EPS beat(16)7.93%
Revenue beat(2)0
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-2.42%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.63%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.69%
Revenue beat(12)2
Avg Revenue beat(12)-2.67%
Revenue beat(16)6
Avg Revenue beat(16)-1.42%
PT rev (1m)0%
PT rev (3m)29.98%
EPS NQ rev (1m)6.05%
EPS NQ rev (3m)17.87%
EPS NY rev (1m)1.17%
EPS NY rev (3m)1.83%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)0.56%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.09%
Valuation
Industry RankSector Rank
PE 8.92
Fwd PE 8.47
P/S 0.85
P/FCF 9.89
P/OCF 5.79
P/B 1.32
P/tB N/A
EV/EBITDA 11.06
EPS(TTM)4.44
EY11.21%
EPS(NY)4.68
Fwd EY11.81%
FCF(TTM)4.01
FCFY10.11%
OCF(TTM)6.84
OCFY17.27%
SpS46.69
BVpS30.11
TBVpS-18.8
PEG (NY)1.68
PEG (5Y)N/A
Graham Number54.84
Profitability
Industry RankSector Rank
ROA -0.19%
ROE -0.67%
ROCE 2.56%
ROIC 1.8%
ROICexc 2%
ROICexgc 6.8%
OM 4.2%
PM (TTM) N/A
GM 56.35%
FCFM 8.58%
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)5.51%
ROIC(5y)N/A
ROICexc(3y)6.21%
ROICexc(5y)N/A
ROICexgc(3y)25.79%
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3Y-23.46%
ROICexgc growth 5Y-1.27%
ROICexc growth 3Y-13.2%
ROICexc growth 5Y2.54%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 10.07
Debt/EBITDA 5.32
Cap/Depr 66.1%
Cap/Sales 6.08%
Interest Coverage 1.09
Cash Conversion 109.39%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.71
Altman-Z 0.96
F-Score5
WACC6.93%
ROIC/WACC0.26
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.99%
EPS 3Y-17.58%
EPS 5Y-7%
EPS Q2Q%-85.26%
EPS Next Y5.3%
EPS Next 2Y6.88%
EPS Next 3Y9.93%
EPS Next 5Y6.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.41%
Revenue Next Year0.65%
Revenue Next 2Y1.52%
Revenue Next 3Y2.48%
Revenue Next 5Y2.62%
EBIT growth 1Y-2.82%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year63.63%
EBIT Next 3Y21.19%
EBIT Next 5Y13.99%
FCF growth 1Y873.08%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y161.6%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%

BAYER AG-REG / BAYN.DE FAQ

What is the fundamental rating for BAYN stock?

ChartMill assigns a fundamental rating of 2 / 10 to BAYN.DE.


What is the valuation status of BAYER AG-REG (BAYN.DE) stock?

ChartMill assigns a valuation rating of 7 / 10 to BAYER AG-REG (BAYN.DE). This can be considered as Undervalued.


How profitable is BAYER AG-REG (BAYN.DE) stock?

BAYER AG-REG (BAYN.DE) has a profitability rating of 1 / 10.


How financially healthy is BAYER AG-REG?

The financial health rating of BAYER AG-REG (BAYN.DE) is 1 / 10.


How sustainable is the dividend of BAYER AG-REG (BAYN.DE) stock?

The dividend rating of BAYER AG-REG (BAYN.DE) is 0 / 10 and the dividend payout ratio is -65.15%.